Meet us at the 13th Annual OCT Southern California 2025
Avance Clinical will be exhibiting at the 13th Annual Outsourcing in Clinical Trials Southern California 2025, held on September 23-24 at the Hyatt Regency La Jolla at Aventine, San Diego.
Search results
We found 173 results for: “phase ii”
Unlocking Global Oncology Success: The Strategic Advantage of Australia & Asia for U.S. Biotechs
This expert panel will explore how Australia, Taiwan, and South Korea provide a strategic advantage in conducting early, mid, and late-phase oncology trials, offering speed, cost efficiency, and global scalability.
Avance Clinical Appoints Mark Harvill as Chief Executive Officer
Avance Clinical, a leading CRO for early-phase and Phase II biotech trials in Australia, the APAC region and the U.S., has appointed Mark Harvill as Chief Executive Officer.
Meet Avance Clinical at BIO Asia-Taiwan 2025
Avance Clinical is excited to participate in the 11th BIO Asia-Taiwan International Convention, held from July 23 - 27, 2025, at the Taipei International Convention Center (TICC), as part of the Australian Pavilion.
Australia Delivers Certainty for US Biotechs in 2025
As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials.
Avance Clinical Clinical Leader Solutions Expo May 2025: CRO Services – Oncology
This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.
Avance Clinical Wins Frost & Sullivan 2025 award
This award recognizes Avance Clinical’s strategic innovation, operational agility, and unwavering commitment to client success in early-phase clinical trials.
Rob Jones
Robert Jones is a clinical research professional who brings over 10 years of CRO experience to his role as Director of Strategic Partnerships at Avance Clinical. Throughout his career, he has built partnerships with biotechs and CROs companies across Europe, the USA, and Asia-Pacific, supporting ...
Strategic Partnership Between Avance Clinical and Kaohsiung Medical University Chung-Ho Memorial Hospital- Strengthens Asia’s Clinical Trial Network
Avance Clinical has signed a Memorandum of Understanding (MOU) with Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), a top-tier clinical research hospital in Taiwan, recognized for its excellence in conducting high-quality clinical trials and its leadership in medical innovation.
Avance Clinical Signs Memorandum of Understanding with Taichung Veterans General Hospital, Expanding Trial Site Network in Taiwan
Avance Clinical signed a Memorandum of Understanding (MOU) with Taichung Veterans General Hospital (TCVGH), one of Taiwan’s leading medical centers with extensive clinical trial expertise.